Tradestie Institutional Equity Comparison Engine

BTO vs BME โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BME Overall Edge

BME Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Blackrock Health Sciences Trust (BME) driven by superior Momentum & Technical. Fundamentally, BTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BME at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BME sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BTO N/M vs BME N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner BME
1Y +12.7% vs +16.7% ยท 52W Pos 53% vs 89%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BTO NYSE
John Hancock Financial Opportunities Fund
Institutional Equity
$37.34
-0.59% 1D
Market Cap $704.9M
1M Return +3.98%
1Y Return +12.71%
Forward P/E N/M
Unified AI Score
43.7 / 100 HOLD
Tech 48.0 Fund 49.0 Flow 50.0 Mom 50.0
BME NYSE
Blackrock Health Sciences Trust
Institutional Equity
$47.08
-1.07% 1D
Market Cap $487.9M
1M Return +6.98%
1Y Return +16.71%
Forward P/E N/M
Unified AI Score
40.9 / 100 SELL
Tech 27.0 Fund 37.0 Flow 50.0 Mom 31.6

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BTO +12.71% BME +16.71% Spread: +4.0 pp (BME Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BTO TTM Op. Margin: N/A BME TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BTO vs BME. Trailing 12-month operating profitability (BTO N/A vs BME N/A) and valuation multiples (BTO N/M vs BME N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BTO (3) vs BME (1)
Institutional Metric BTO BME Criterion Row Winner
Market Capitalization Scale $704.9M $487.9M Larger Scale BTO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 53% ($32โ€“$42) 89% ($38โ€“$48) Stronger Trend BME
Beta / 30D Volatility Risk Regime 0.51ฮฒ ยท 18% Vol 0.42ฮฒ ยท 19% Vol Lower Realized Risk BTO
Unified Institutional Score Composite Signal 43.7 / 100 (HOLD) 40.9 / 100 (SELL) Higher Composite BTO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BTO vs BME Buy Guide
BTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BME UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BME Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BTO nor BME registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.